Satvik Pharma is a trusted pharmaceutical wholesale distributor supplying genuine, high-quality medicines to pharmacies, hospitals and healthcare institutions — from Critical Care Injectables and Oncology to HIV and Cardio-Diabetic medicines, sourced from reputed manufacturers.
Time-sensitive, high-stakes injectable therapies moved through validated cold-chain and ambient lanes, for ICU and emergency-care settings.
Chemotherapy and supportive-care oncology products, handled under strict batch integrity and traceable dispatch to hospital pharmacies.
Antiretroviral therapy lines supplied on continuity-of-care terms, so pharmacies and institutions never face an avoidable stock gap.
The high-frequency chronic-care backbone — cardiac and anti-diabetic formulations kept in steady, predictable stock rotation.
A wider catalogue of formulations sourced from reputed manufacturers, rounding out a full-service order for any single institution.
Circumcision staplers, suction machines, vaginal specula, surgical forceps and diagnostic instruments, supplied alongside our medicine range for a single-source order.
Place, confirm and track an order over WhatsApp — the same channel our pharmacy and hospital partners already use every day.
Our full catalogue runs well beyond this list. Share your requirement over WhatsApp and we'll confirm availability, pricing and dispatch time directly.
A pharmacy, hospital or institution sends its requirement over WhatsApp or by phone, referencing the products and quantities needed.
Stock is drawn from reputed manufacturers and checked against batch and expiry records before it is released for dispatch.
Orders are packed under conditions appropriate to the product — including cold-chain handling for temperature-sensitive lines.
Goods reach the counterparty's registered premises, with the tax invoice and batch reference accompanying every consignment.
"Satvik" means pure, wholesome, essential. A medicine that reaches a patient late, or in doubt, has already failed them.— The Satvik Pharma standard
Satvik Pharma is a trusted pharmaceutical wholesale distributor committed to supplying genuine, high-quality medicines to pharmacies, hospitals and healthcare institutions. We specialise in Critical Care Injectables, Oncology Medicines, HIV Medicines, Cardio-Diabetic Medicines and a wide range of other pharmaceutical products, sourced from reputed manufacturers.
With a strong focus on quality, timely delivery, competitive pricing and regulatory compliance, we strive to provide reliable healthcare supply solutions. Our website and WhatsApp ordering platform make ordering simple, fast and convenient for our customers.
Satvik Pharma is a pharmaceutical wholesale distributor registered as a proprietorship under Rajendra Gehlot, operating out of Pune, Maharashtra. The business supplies genuine, high-quality medicines to pharmacies, hospitals and healthcare institutions across its trade network.
The portfolio is built around the categories that matter most in a functioning healthcare supply chain — Critical Care Injectables, Oncology Medicines, HIV Medicines and Cardio-Diabetic Medicines — supported by a wider general pharmaceutical range, all sourced from reputed manufacturers.
Every order is held to the same four commitments: quality that a pharmacy or hospital can trust without re-checking, timely delivery that respects how urgent a medicine order usually is, competitive pricing that keeps supply sustainable for both sides, and regulatory compliance that never treats paperwork as optional.
Stock is drawn only from reputed manufacturers, with batch and expiry verification before anything is released for dispatch.
Products are held under conditions appropriate to their nature — including cold-chain discipline for temperature-sensitive lines.
Orders move from confirmation to delivery on a predictable timeline, with a tax invoice and batch reference on every consignment.
Injectable therapies for ICU, emergency and critical-care settings — moved on validated lanes with cold-chain handling wherever the product label requires it.
Chemotherapy and supportive-care products supplied to hospital pharmacies and oncology centres, with strict attention to batch integrity and shelf-life.
Antiretroviral and related therapy lines supplied with a focus on continuity, so treatment programmes are not interrupted by an avoidable stock-out.
The steady, high-frequency backbone of chronic-care supply — cardiac and anti-diabetic formulations kept in predictable, well-rotated stock.
A wider catalogue of formulations across additional therapeutic categories, allowing a pharmacy or hospital to consolidate more of its order in one place.
Circumcision staplers, suction machines, vaginal specula, surgical forceps and diagnostic instruments such as pocket otoscopes and proctoscopes — supplied alongside our medicine range.
Orders are placed, confirmed and tracked over WhatsApp — the same everyday channel our trade partners already use, kept simple and fast on purpose.
Retail and institutional pharmacies place standing or one-off orders over WhatsApp, with invoicing and batch traceability on every dispatch.
Hospital procurement teams source critical-care, oncology and chronic-care lines against confirmed stock, with delivery timed to clinical need.
Clinics, nursing homes and healthcare programmes access the same reliable supply — including continuity-focused categories like HIV medicines.
1st Floor, No. 1 & A-2, Rajyog Annexe, Survey No. 26/4, 31/2, 31/3/1, Sinhgad Road, Behind Lokmat Office, Village Vadgaon Khurd, Pune, Maharashtra — 411041
Same number serves voice calls and WhatsApp ordering. This number is provisional and subject to change.
GSTIN 27BMLPG9856Q1ZX
Constitution Proprietorship
Satvik Pharma is a pharmaceutical wholesale distributor registered as a proprietorship, operating from Pune, Maharashtra, under GSTIN 27BMLPG9856Q1ZX. The business supplies genuine medicines to pharmacies, hospitals and healthcare institutions.
The portfolio covers Critical Care Injectables, Oncology Medicines, HIV Medicines, Cardio-Diabetic Medicines and a wider general pharmaceutical range, all sourced from reputed manufacturers.
Orders are placed directly over WhatsApp or phone on +91 97300 50077. Once the requirement is confirmed against stock, the order is packed and dispatched with a tax invoice and batch reference.
No. Satvik Pharma operates on a business-to-business basis, supplying pharmacies, hospitals and healthcare institutions. Patients should obtain Satvik-supplied medicines from their licensed pharmacy or treating hospital.
Yes. Satvik Pharma is registered under GSTIN 27BMLPG9856Q1ZX, approved by the Maharashtra state tax authority with effect from 07 December 2020. The GSTIN appears on every tax invoice issued.
Stock is sourced only from reputed manufacturers and checked against batch and expiry records before dispatch. Temperature-sensitive products, including select injectables, are handled under cold-chain conditions appropriate to the product label.
Deliveries are made to verified trade addresses of pharmacies, hospitals and healthcare institutions. Serviceability for a specific location is confirmed directly at the time an order is placed.
Product complaints, batch-quality concerns or delivery discrepancies can be reported directly on +91 97300 50077 by phone or WhatsApp, with the relevant invoice or batch reference where available.
How Satvik Pharma collects, uses, retains and protects information belonging to trade partners and visitors interacting with the business.
This privacy policy describes how Satvik Pharma (the Business, we, our) handles personal and business information collected through trade interactions, telephone and WhatsApp correspondence on +91 97300 50077, and any digital channels operated by the Business. It applies to information about authorised contacts of pharmacies, hospitals, institutional buyers and other counterparties.
We collect: (a) identity and contact information such as full name, designation, organisation, business address, telephone, email and statutory identifiers (GSTIN, drug-licence number); (b) commercial information including order history, invoices, payment references and delivery acknowledgements; (c) technical information from electronic communication including device and timestamp metadata where applicable; and (d) product-quality information voluntarily reported in connection with a complaint or delivery discrepancy.
Information is processed on the lawful bases of contract performance, statutory obligation under Indian pharmaceutical and tax law, and legitimate business interest in operating a regulated supply chain. Purposes include order fulfilment, invoicing, drug-licence verification, regulatory reporting, audit compliance and protection against fraud or product diversion.
We share information with: (a) statutory and regulatory authorities where disclosure is required by law; (b) authorised logistics and payment partners strictly to perform a service requested; (c) professional advisers under appropriate confidentiality obligations. We do not sell personal information.
We retain information for the period required to satisfy the purposes above and to comply with applicable record-keeping obligations under the GST regime and the Drugs and Cosmetics Act. On expiry of that period, records are securely deleted or anonymised.
We apply administrative, technical and physical safeguards proportionate to the sensitivity of the data, including access control and incident-response procedures. No transmission method is perfectly secure; we ask counterparties to apply equivalent diligence on their side.
Subject to applicable law, you may request access to, correction of, restriction on, or deletion of personal information we hold about you. Requests may be made to the registered office or to +91 97300 50077. We will respond within a reasonable timeframe, subject to verification of identity and any overriding statutory record-keeping obligation.
This policy may be updated from time to time; the effective version is the one published on the Business's website. It is governed by Indian law, and the courts at Pune, Maharashtra have exclusive jurisdiction over any dispute arising in connection with it.
The terms below govern access to and use of the Business's website, communications and trade-channel interactions. By engaging with the Business, the counterparty accepts these terms.
'Business' means Satvik Pharma, a proprietorship of Rajendra Gehlot (GSTIN 27BMLPG9856Q1ZX), having its registered office at Pune, Maharashtra. 'Counterparty', 'you' or 'your' means any person or entity engaging with the Business in a commercial or informational capacity. 'Goods' means pharmaceutical products supplied by the Business.
Trade orders may be placed only by entities holding a valid drug licence and other applicable statutory registrations. By placing an order, the counterparty represents that all such registrations are current and that the contact person is authorised to bind the entity. The Business reserves the right to verify documentation and to decline or discontinue dealings where verification is not satisfied.
An order placed through accepted channels constitutes an offer to purchase. The Business's acceptance occurs on dispatch confirmation; until that point, the Business may decline an order in whole or in part. Prices are exclusive of taxes unless stated; applicable GST is charged on every invoice. The Business may revise prices for future orders without notice.
Payment is due against the terms communicated at order acceptance — pro-forma, on delivery, or on agreed credit. Outstanding amounts beyond the agreed period may attract interest at the rate notified, suspension of further dispatch, and recovery proceedings under applicable law.
Risk in the Goods passes on delivery to the counterparty or to a logistics partner nominated by the counterparty. Title in the Goods remains with the Business until full payment is received. Acceptance is deemed unless a written discrepancy notice is served within the timeframe set out in the Refund & Returns Policy.
The counterparty undertakes to handle, store, dispense and resell the Goods in compliance with the Drugs and Cosmetics Act and applicable rules, including cold-chain requirements where stated. The counterparty shall not tamper with packaging or labelling and shall maintain records sufficient for batch traceability.
All trademarks, brand elements and digital assets remain the exclusive property of the Business or its licensors. Reproduction, adaptation or commercial reuse without prior written consent is prohibited.
Subject to applicable law, the Business's aggregate liability arising out of or in connection with any single order shall not exceed the invoice value of that order. The Business shall not be liable for indirect, incidental, consequential or punitive damages, except where such limitation is excluded by mandatory statute.
Neither party is liable for delay or failure caused by events outside reasonable control — including natural disaster, public-health emergency, regulatory action, transport disruption or supply-chain failure — provided notice is given and reasonable mitigation undertaken.
These terms are governed by the laws of India. The courts at Pune, Maharashtra have exclusive jurisdiction over any dispute, claim or proceeding arising out of or in connection with these terms or any transaction governed by them.
Pharmaceutical returns are tightly regulated for patient-safety reasons. The terms below describe the limited circumstances under which returns are accepted and how refunds are processed.
As a regulated pharmaceutical supplier, the Business does not accept returns of correctly supplied Goods on grounds of changed buying preference. Returns are limited to the scenarios below and are subject to verification.
Returns are eligible where: (a) Goods were supplied in error against the confirmed order; (b) Goods were damaged in transit and the damage was recorded on the proof of delivery; (c) Goods were received with a manufacturing defect or short shelf-life inconsistent with the order; or (d) a regulatory recall has been initiated.
Discrepancies under heads (a) and (b) must be notified within seven (7) calendar days of receipt with photographic evidence and the original delivery acknowledgement. Defects under head (c) must be notified within thirty (30) calendar days of receipt, or within seven (7) days of detection where the defect could not reasonably have been found earlier.
Returned Goods must be in original primary and secondary packaging, with intact batch and expiry information, free of any tampering or relabelling, and accompanied by the relevant invoice number and a signed return authorisation issued by the Business.
Cold-chain products are accepted for return only where temperature integrity throughout the chain can be evidenced by data logger or equivalent record. A cold-chain breach disqualifies a return regardless of physical condition.
Approved returns are credited against future invoices, or refunded to the originating bank account at the Business's discretion, within fourteen (14) working days of acceptance of the returned consignment. GST adjustments are processed through a compliant credit note.
Any dispute regarding a return or refund shall be raised in writing to the registered office. Unresolved disputes are subject to the exclusive jurisdiction of the courts at Pune, Maharashtra, and governed by Indian law.
How orders accepted by the Business are processed, dispatched, transported and delivered to verified trade partners.
The Business dispatches Goods to verified trade addresses where the counterparty holds a valid drug licence and where the Business is in a position to serve under prevailing logistics and regulatory conditions. Service to a particular location is confirmed at order acceptance.
Confirmed orders are typically picked, packed and dispatched within two (2) to four (4) working days of acceptance, subject to product availability and successful drug-licence verification. Cold-chain consignments may follow a separate dispatch cadence.
Dispatch is undertaken through logistics partners selected for pharmaceutical handling capability and, where applicable, cold-chain qualification. Tracking references, where issued by the carrier, are shared with the counterparty's nominated contact.
Temperature-sensitive Goods are dispatched in qualified shipper systems with data loggers as required by product label. The counterparty is asked to inspect the logger record on receipt; any excursion must be flagged before unpacking and stocking.
On delivery, the counterparty's representative must inspect the consignment for parcel count and visible damage and record any discrepancy on the proof of delivery. Acceptance without such notation is treated as acknowledgement of correct delivery.
Logistics charges, where applicable, are stated at order acceptance and itemised on the invoice. Insurance, where elected, covers transit risk up to the value declared.
Where delivery cannot be completed because the consignee is unavailable or refuses receipt, Goods are returned to the nearest hub; re-dispatch attracts further charges, and short-shelf-life Goods may be quarantined.
Dispatch and shipping queries are routed through +91 97300 50077 on voice or WhatsApp. Unresolved escalations may be addressed in writing to the registered office at Pune, Maharashtra.